Our results are consistent with these mechanisms: TCDD injection significantly increased hepatic and serum TG levels and lipid droplet formation in WT mice, while reducing mitochondrial OCR, suggesting impaired fatty acid utilization leading to steatosis under AhR activation. Here, AHR is linked to steatosis.